Epi-Seq: Epigenome Landscape Mapping for Clinical and Drug Discovery Settings

It’s no longer enough to look at a single histone modification at a single gene. Publishing in high impact journals and being awarded competitive research grants is now requiring a more comprehensive picture of the epigenomic landscape. More histone modifications need to be investigated in each sample, and on a genome-wide scale.

This poster describes Epi-Seq, a complete experimental solution that will dramatically reduce the technical expertise and touch-time needed to perform ChIP-Seq, while also increasing consistency and throughput.

Epigenetics and Drug Discovery